The Patent Finder

Terms ending in 2030

Phio Pharmaceuticals Corp.

Every in-force patent on Phio Pharmaceuticals Corp.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,167,471Inhibition of PCSK9 Through Rnai
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 9,745,574RNA Duplexes with Single Stranded Phosphorothioate Nucleotide Regions for Additional Functionality
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 10,479,992RNA Duplexes with Single Stranded Phosphorothioate Nucleotide Regions for Additional Functionality
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In forceMedium confidence
US 11,667,915RNA Duplexes with Single Stranded Phosphorothioate Nucleotide Regions for Additional Functionality
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In forceMedium confidence
US 8,796,443Reduced Size Self-Delivering Rnai Compounds
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In forceMedium confidence
US 9,074,211Inhibition of MAP4K4 Through Rnai
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited